1.Comparision of the Two Groups between Autologous Bone Chips and Cage as Posterior Lumbar Interbody Fusion in Spondylolisthesis Patients.
Pill Jae SHIN ; Chang Hyun KIM ; Jae Gon MOON ; Ho Kook LEE ; Do Yun HWANG
Journal of Korean Neurosurgical Society 2000;29(4):507-513
No abstract available.
Humans
;
Spondylolisthesis*
2.Management of hand degloving injuries with sandwich flaps.
Jae Deok KIM ; sung Pill CHO ; Ki Taek HAN ; Sung Shin WEE
Journal of the Korean Society of Plastic and Reconstructive Surgeons 1993;20(4):868-874
No abstract available.
Hand*
3.Rhinocerebral Mucormycosis with Intracerebral Hemorrhage.
Pill Jae SHIN ; Ho Kook LEE ; Chang Hyun KIM ; Kyung Hun YANG ; Do Yun HWANG
Journal of Korean Neurosurgical Society 2000;29(1):136-142
No abstract available.
Cerebral Hemorrhage*
;
Mucormycosis*
4.A clinical consideration for 41 cases of resectoscopic surgery in gynecology.
Ahn Soo YI ; Kyung Do PARK ; Hong Pill KIM ; Seong Rim KIM ; In Jae KIM ; Ki Sung CHUNG
Korean Journal of Obstetrics and Gynecology 1993;36(7):2544-2550
No abstract available.
Gynecology*
5.Implant-supported milled bar overdenture with two implant surgical guides
Pill-Sang YUN ; Sunjai KIM ; Se-Wook PYO ; Jae-Seung CHANG
The Journal of Korean Academy of Prosthodontics 2023;61(1):55-62
For fully edentulous patients, implant-supported overdenture can be considered to enhance chewing efficiency and denture stability. Implant planning software can be used to fabricate a surgical guide for a more precise consideration of anatomic factors and prediction of the shape of definitive prosthesis. Though there are many possible attachments for implant overdenture, milled bar can be useful due to its splinting effect of implants and rigid support of overdenture. This report presents a case of implant-supported milled bar overdenture after guided implant surgery performed with two surgical guide that was fabricated before and after bone reduction.
6.Tussilagone suppressed the production and gene expression of MUC5AC mucin via regulating nuclear factor-kappa B signaling pathway in airway epithelial cells.
Byung Soo CHOI ; Yu Jin KIM ; Yong Pill YOON ; Hyun Jae LEE ; Choong Jae LEE
The Korean Journal of Physiology and Pharmacology 2018;22(6):671-677
In the present study, we investigated whether tussilagone, a natural product derived from Tussilago farfara, significantly affects the production and gene expression of airway MUC5AC mucin. Confluent NCI-H292 cells were pretreated with tussilagone for 30 min and then stimulated with EGF (epidermal growth factor) or PMA (phorbol 12-myristate 13-acetate) for 24 h or the indicated periods. The MUC5AC mucin gene expression was measured by RT-PCR. Production of MUC5AC mucin protein was measured by ELISA. To elucidate the action mechanism of tussilagone, effect of tussilagone on PMA-induced NF-κB signaling pathway was investigated by western blot analysis. Tussilagone significantly inhibited the production of MUC5AC mucin protein and down-regulated the expression of MUC5AC mucin gene, induced by EGF or PMA. Tussilagone inhibited PMA-induced activation (phosphorylation) of inhibitory kappa B kinase (IKK), and thus phosphorylation and degradation of inhibitory kappa Ba (IκBα). Tussilagone inhibited PMA-induced phosphorylation and nuclear translocation of nuclear factor kappa B (NF-κB) p65. This, in turn, led to the down-regulation of MUC5AC protein production in NCI-H292 cells. These results suggest that tussilagone can regulate the production and gene expression of mucin by acting on airway epithelial cells through regulation of NF-κB signaling pathway.
Blotting, Western
;
Down-Regulation
;
Enzyme-Linked Immunosorbent Assay
;
Epidermal Growth Factor
;
Epithelial Cells*
;
Epithelium
;
Gene Expression*
;
Mucins*
;
NF-kappa B
;
Phosphorylation
;
Phosphotransferases
;
Tussilago
7.Clinical Study of Lung Cancer.
Pill Young KIM ; Jung Kyu CHOI ; Myung Soo HYUN ; Chong Suhi KIM ; Young Hyun LEE ; Jae Chun CHUNG ; Chong Suhi KIM
Yeungnam University Journal of Medicine 1986;3(1):201-207
159 histologically proved cases of lung cancer have been reviewed at the Department of Internal Medicine, Yeungnam University Medical School for the past two years and six months from January, 1984 to July 1986. 1. The age distribution ranged from 27 to 87 years and 69.2% of the patient were distributed between the ages of 51 and 70. 2. The ratio of male and female was 4.6 : 1 (131 males, 28 females) 3. Chief complains were in order of dyspnea, chest pain, cough, hemoptysis and weight loss. 4. Localization on chest film. Right was more than left (right 58.6%, left 36.2%) and the most frequent site is right upper lung field (33 cases, 21.7%) 6. 76.8% of case was diagnosed histologically under the bronchoscopic biopsy. 8. The most common treatment was conservative therapy In general. However chemotherapy was most common treatment of the small cell type carcinoma.
Age Distribution
;
Biopsy
;
Chest Pain
;
Clinical Study*
;
Cough
;
Drug Therapy
;
Dyspnea
;
Female
;
Hemoptysis
;
Humans
;
Internal Medicine
;
Lung Neoplasms*
;
Lung*
;
Male
;
Schools, Medical
;
Thorax
;
Weight Loss
8.Clinical Review for the Some Patients of Lung Cancer in Pusan - Kyungnam Area.
Sung Hyun KIM ; Young Ki SON ; Chng Hoon MOON ; Jae Seok KIM ; Hyo Jin KIM ; Hyung Sik LEE ; Won Joo HUR ; Pill Joe CHOI ; Jong Su WOO
Journal of the Korean Cancer Association 1998;30(6):1103-1109
PURPOSE: This study was performed to find out the natural history of lung cancer in Pusan-Kyungnam area and changing of that in previous report. MATERIALS AND METHOD: We studied retrospectively 508 patients with pathologically proven lung cancer from January 1991 to December 1995. We analysed age and sex distribution, initial symptoms before diagnosis, first method yielding histologic diagnosis, cell types of lung cancer, initial stage of lung cancer, schema of overall patients, survivial of lung cancer patients, and prognostic factors affecting survival of lung cancer patients.. RESULTS: The overall male to female ratio was 4.5: 1 and the age distribution ranged from 20 to 86 years, and the median age of overall patients was 60 years. Histologic classification revealed that the most prevalent type was squamous cell carcinoma (251 cases, 49.4%), followed by adenocarcinoma (141 cases, 27.8%), small cell carcinoma (91 cases, 17.9%), and large cell carcinoma (3 cases, 0.6%). In non-smali cell lung cancer 56.8% were stage IIIb and IV, therefore curative operation was done in 18.7% of all cases, but in small cell lung cancer 65.6% were extended disease. Meidan survival of overall patients was 11.8 months. There was a quite difference in survival among the stages. In non-small cell lung cancer, median survival was 59.7 months, 27.3 months, 18.5 months, 12.7 months, 5.9 months in stage I, II, IIIa, IIIb, IV in each. In small cell lung cancer, median survival of limited disese was 12.2 months and median survival of extended disease was 6.7 months. The stage and the performance status were independent prognostic factors in both small cell and non-small cell lung cancer. CONCLUSION: The prognosis of patients with lung cancer was still grave, but the survival was better than that of a previous report. This may be accorded to increase in early diagnosis and operation and advance in supportive care.
Adenocarcinoma
;
Age Distribution
;
Busan*
;
Carcinoma, Large Cell
;
Carcinoma, Non-Small-Cell Lung
;
Carcinoma, Small Cell
;
Carcinoma, Squamous Cell
;
Classification
;
Diagnosis
;
Early Diagnosis
;
Female
;
Gyeongsangnam-do*
;
Humans
;
Lung Neoplasms*
;
Lung*
;
Male
;
Natural History
;
Prognosis
;
Retrospective Studies
;
Sex Distribution
;
Small Cell Lung Carcinoma
9.Islet Cell Tumors of the Pancreas.
Jae Pill JUNG ; Song Cheal KIM ; Tae Hee KIM ; Hyuk Jai JANG ; Duck Jong HAN
Journal of the Korean Surgical Society 2000;58(6):840-850
PURPOSE: Islet cell tumors are a rare disease that can be cured by surgical management if they are early diagnosed. However, diagnosis and localization are difficult due to their small size and varied clinical manifestations. We analyzed the clinicopathologic features, the diagnosis and the surgical management of islet cell tumors. METHODS: We retrospectively analyzed the case histories of 30 patients had undergone pancreatic surgery for islet cell tumors between April 1990 and December 1999. RESULTS: The islet-cell tumors included 16 insulinomas, 4 gastrinomas, 1 glucagonoma, one insulin-gastrin secreting tumor, and 8 nonfunctioning tumors. The major clinical manifestations were neuroglycopenic (94%) and adrenergic (75%) symptoms in cases of an insulinoma, abdominal ulcer symptoms (100%) in the cases of a gastrinoma, diabetis mellitus (100%) in the cases of a glucagonoma, and abdominal pain (63%) and a mass (25%) in nonfunctioning tumor. The preoperative tumor localization tools were angiography, transhepatic portal vein sampling, endoscopic ultrasonography, computed tomography, and octreotide scans which had sensitivities of 56%, 71%, 55.5%, 43.3%, and, 25% respectively. The surgical treatments were enucleation (38%) or segmental resection (25%) for insulinomas, pancreaticoduodenectomy with total gastrectomy (25%) or total pancreatectomy (25%) for gastrinomas, and pylorus preserving pancre aticoduodenectomy (38%) or regional pancreatectomy (26%) for nonfunctioning tumors. Malignant islet cell tumors were presenting cases (30%). Two patients died with postoperative complications on post operative day 3 and 35; the others survived during the follow-up period (1 month-10 years). Islet cell tumors with multiple endocrine neoplasm type I occurred in five (17%) cases; in three cases, the tumors were malignant. CONCLUSION: The early diagnosis and vigorous attempt to resect the lesion in islet cell tumors of the pancreas should be carried out for the long-term survival.
Abdominal Pain
;
Adenoma, Islet Cell*
;
Angiography
;
Diagnosis
;
Early Diagnosis
;
Endosonography
;
Follow-Up Studies
;
Gastrectomy
;
Gastrinoma
;
Glucagonoma
;
Humans
;
Insulinoma
;
Islets of Langerhans*
;
Octreotide
;
Pancreas*
;
Pancreatectomy
;
Pancreaticoduodenectomy
;
Portal Vein
;
Postoperative Complications
;
Pylorus
;
Rare Diseases
;
Retrospective Studies
;
Ulcer
10.Parthenogenetic Mouse Embryonic Stem Cells have Similar Characteristics to In Vitro Fertilization mES Cells.
Se Pill PARK ; Eun Young KIM ; Keum Sil LEE ; Young Jae LEE ; Hyun Ah SHIN ; Hyun Jung MIN ; Hoon Taek LEE ; Kil Saeng CHUNG ; Jin Ho LIM
Korean Journal of Fertility and Sterility 2002;29(2):129-138
OBJECTIVE: This study was to compare the characteristics between parthenogenetic mES (P-mES) cells and in vitro fertilization mES cells. MATERIAL AND METHODS: Mouse oocytes were recovered from superovulated 4 wks hybrid F1 (C57BL/6xCBA/N) female mice. For parthenogenetic activation, oocytes were treated with 7% ethanol for 5 min and 5microgram/ml cytochalasin-B for 4 h. For IVF, oocytes were inseminated with epididymal perm of hybrid F1 male mice(1x106/ml). IVF and parthenogenetic embryos were cultured in M16 medium for 4 days. Cell number count of blastocysts in those two groups was taken by differential labelling using propidium iodide (red) and bisbenzimide (blue). To establish ES cells, blastocysts in IVF and parthenogenetic groups were treated by immunosurgery and recovered inner cell mass (ICM) cells were cultured in LIF added ES culture medium. To identity ES cells, the surface markers alkaline phosphatase, SSEA-1, 3, 4 and Oct4 staining were examined in replated ICM colonies. Chromosome numbers in P-mES and mES were checked. Also, in vitro differentiation potential of P-mES and mES was examined. RESULTS: Although the cleavage rate (> or =2-cell) was not different between IVF (76.3%) and parthenogenetic group (67.0%), in vitro development rate was significantly low in parthenogenetic group (24.0%) than IVF group (68.4%) (p<0.05). Cell number count of ICM and total cell in parthenogenetic blastocysts (9.6+/-3.1, 35.1+/-5.2) were significantly lower than those of IVF blastocysts (19.5+/-4.7, 63.2+/-13.0) (p<0.05). Through the serial treatment procedure such as immunosurgery, plating of ICM and colony formation, two ICM colonies in IVF group (mES, 10.0%) and three ICM colonies (P-mES, 42.9%) in parthenogenetic group were able to culture for extended duration (25 and 20 passages, respectively). Using surface markers, alkaline phosphatase, SSEA-1 and Oct4 in P-mES and mES colony were positively stained. The number of chromosome was normal in ES colony from two groups. Also, in vitro neural and cardiac differentiation derived from mES or P-mES cells was confirmed. CONCLUSION: This study suggested that P-mES cells can be successfully established and that those cell lines have similar characteristics to mES cells.
Alkaline Phosphatase
;
Animals
;
Antigens, CD15
;
Bisbenzimidazole
;
Blastocyst
;
Cell Count
;
Cell Line
;
Embryonic Stem Cells*
;
Embryonic Structures
;
Ethanol
;
Female
;
Fertilization in Vitro*
;
Humans
;
Male
;
Mice*
;
Oocytes
;
Propidium